Efficacy and safety of uninterrupted periprocedural edoxaban in patients undergoing catheter ablation for atrial fibrillation: Prospective KYU-RABLE study

Back

ESC Premium Access

Efficacy and safety of uninterrupted periprocedural edoxaban in patients undergoing catheter ablation for atrial fibrillation: Prospective KYU-RABLE study

Session: Perspectives on anticoagulation across cardiovascular disease

Topic: Anticoagulants

Speaker: Professor N. Takahashi (Oita, JP)

Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Naohiko Takahashi

Oita University Faculty of Medicine, Oita (Japan)

0 follower

7 more presentations in this session

Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.

Speaker: Mr A. Capiau (Ghent, BE)

Potential real-world benefits of low-dose rivaroxaban in Chinese stable cardiovascular patients

Speaker: Associate Professor B. Yan (Hong Kong, CN)

Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: a prospective cohort study.

Speaker: Doctor M. Vedovati (Perugia, IT)

Risk of arterial calcification by conventional vitamin K antagonist treatment

Speaker: Doctor S. Hasific (Odense, DK)

Real world persistence with direct oral anticoagulants in anticoagulation naive patients with atrial fibrillation

Speaker: Doctor G. Denas (Padova, IT)

Access the full session

Perspectives on anticoagulation across cardiovascular disease

Speakers: Professor N. Takahashi, Mr A. Capiau, Associate Professor B. Yan, Doctor M. Vedovati, Doctor S. Hasific...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Efficacy and safety of uninterrupted periprocedural edoxaban in patients undergoing catheter ablation for atrial fibrillation: Prospective KYU-RABLE study

About the speaker

Professor Naohiko Takahashi

7 more presentations in this session

Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.

Potential real-world benefits of low-dose rivaroxaban in Chinese stable cardiovascular patients

Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: a prospective cohort study.

Risk of arterial calcification by conventional vitamin K antagonist treatment

Real world persistence with direct oral anticoagulants in anticoagulation naive patients with atrial fibrillation

Access the full session

Perspectives on anticoagulation across cardiovascular disease

About the event

ESC Congress 2019

ESC 365 is supported by